Metraipolis › archive › dc_da7e7fa314cc

Genomic Therapy Matching in Rare and Refractory Cancers — Europe PMC PMID:41784981

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41784981
DOI: 10.1001/jamaoncol.2026.0127
License (as archived): solo-consultazione
Archived: 2026-11-02T22:26:45.543Z
SHA-256 of the archived text: 07e76c40563d61c6a6f4f01e026feabf4c00215f866a5f9f77eaaf312c669036
Stable URL of this page: https://metraipolis.com/documento/dc_da7e7fa314cc

How to cite

Genomic Therapy Matching in Rare and Refractory Cancers — Europe PMC PMID:41784981 — Europe PMC (en), https://europepmc.org/article/MED/41784981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da7e7fa314cc (Metraipolis archive dc_da7e7fa314cc, sha256 07e76c40563d61c6a6f4f01e026feabf4c00215f866a5f9f77eaaf312c669036)

BibTeX

@misc{dcda7e7fa314cc,
  title = {Genomic Therapy Matching in Rare and Refractory Cancers — Europe PMC PMID:41784981},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41784981},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da7e7fa314cc; sha256 07e76c40563d61c6a6f4f01e026feabf4c00215f866a5f9f77eaaf312c669036},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41784981. Agents can read the archived copy with the MCP tool read_document.